The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Tsai, G. E.
* Articles by Gunther, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Tsai, G. E.
* Articles by Gunther, J.
Related Collections
* Alzheimer's Disease
J Neuropsychiatry Clin Neurosci 10:224-226, May 1998
© 1998 American Psychiatric Press, Inc.


Clinical and Research Report

A Preliminary Study of D-Cycloserine Treatment in Alzheimer's Disease

Guochuan E. Tsai, M.D., Ph.D., William E. Falk, M.D. and Jeanette Gunther, M.S.

Received November 8, 1996; revised Februray 3, 1997; accepted February 5, 1997. From the Geriatric Neurobehavioral Clinic and Laboratory of Molecular and Developmental Neuroscience, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts. Address correspondence to Dr. Tsai, Milman Research Center, McLean Hospital, Belmont, MA 02178; e-mail: TSAIG{at}Helix.MGH.Harvard.EDU

D-cycloserine is a partial agonist on the glycine site of the N-methyl-D-aspartate glutamate receptor. This double-blind crossover study of 15 mg D-cycloserine in Alzheimer's disease patients did not demonstrate clinical benefit. Higher medication dosage or long-term treatment may be required.

Key Words: D-cycloserine • N-methyl-D-aspartate • Alzheimer's Disease




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
K. J. Ressler, B. O. Rothbaum, L. Tannenbaum, P. Anderson, K. Graap, E. Zimand, L. Hodges, and M. Davis
Cognitive Enhancers as Adjuncts to Psychotherapy: Use of D-Cycloserine in Phobic Individuals to Facilitate Extinction of Fear
Arch Gen Psychiatry, November 1, 2004; 61(11): 1136 - 1144.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
W. E. FALK, E. J. DALY, G. E. TSAI, J. GUNTHER, and P. BROWN
A Case Series of D-Cycloserine Added to Donepezil in the Treatment of Alzheimer's Disease
J Neuropsychiatry Clin Neurosci, November 1, 2002; 14(4): 466 - 467.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. E. Tsai, W. E. Falk, J. Gunther, and J. T. Coyle
Improved Cognition in Alzheimer's Disease With Short-Term D-Cycloserine Treatment
Am J Psychiatry, March 1, 1999; 156(3): 467 - 469.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org